John B. Moriarty, Jr.

2019

In 2019, John B. Moriarty, Jr. earned a total compensation of $2.8M as Executive Vice President, General Counsel and Secretary at Portola Pharmaceuticals, a 35% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$210,600
Option Awards$1,542,030
Salary$520,000
Stock Awards$508,125
Other$41,184
Total$2,821,939

Moriarty received $1.5M in option awards, accounting for 55% of the total pay in 2019.

Moriarty also received $210.6K in non-equity incentive plan, $520K in salary, $508.1K in stock awards and $41.2K in other compensation.

Rankings

In 2019, John B. Moriarty, Jr.'s compensation ranked 4,327th out of 13,971 executives tracked by ExecPay. In other words, Moriarty earned more than 69.0% of executives.

ClassificationRankingPercentile
All
4,327
out of 13,971
69th
Division
Manufacturing
1,588
out of 5,701
72nd
Major group
Chemicals And Allied Products
556
out of 2,200
75th
Industry group
Drugs
468
out of 1,886
75th
Industry
Pharmaceutical Preparations
356
out of 1,398
75th

Pay ratio

John B. Moriarty, Jr.'s Pay$2,821,939
Median Employee's Pay$291,408
Pay Ratio

10

to 1

In 2019, the annual total compensation of John B. Moriarty, Jr. was $2,821,939.

The annual total compensation of the median employee at Portola Pharmaceuticals was $291,408.

The ratio of John B. Moriarty, Jr.'s pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 20, 2020.

Moriarty's colleagues

We found four more compensation records of executives who worked with John B. Moriarty, Jr. at Portola Pharmaceuticals in 2019.

2019

Scott Garland

Portola Pharmaceuticals

Chief Executive Officer

2019

Sheldon Koenig

Portola Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2019

Ernie Meyer

Portola Pharmaceuticals

Chief Human Resources Officer

2019

Mardi Dier

Portola Pharmaceuticals

Executive Vice President, Chief Financial and Business Officer

News

In-depth

You may also like